Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer

Drug resistance is an obstacle to the effective treatment of ovarian cancer. We and others have shown that the insulin-like growth factor (IGF) signaling pathway is a novel potential target to overcome drug resistance. The purpose of this study was to validate IGF2 as a potential therapeutic target...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer-Visser, Jurriaan, Lee, Jiyeon, McCullagh, KellyAnne, Cossio, Maria J., Wang, Yanhua, Huang, Gloria S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059749/
https://www.ncbi.nlm.nih.gov/pubmed/24932685
http://dx.doi.org/10.1371/journal.pone.0100165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059749/
https://www.ncbi.nlm.nih.gov/pubmed/24932685
http://dx.doi.org/10.1371/journal.pone.0100165

Ejemplares similares